The Filing Desk

Cytek Biosciences vs Mesa Laboratories

Cytek Biosciences CTKB · Mesa Laboratories MLAB · Life Sciences Tools & Services

Mesa Laboratories reported revenue of $249 million in fiscal 2026, 1.2 times Cytek Biosciences' $202 million in fiscal 2025. Cytek Biosciences' revenue grew 0.5% in its latest year, and Mesa Laboratories' grew 3.4%. Cytek Biosciences had an operating margin of -20.0%, against 7.4% at Mesa Laboratories. Free cash flow was −$9 million at Cytek Biosciences and $40 million at Mesa Laboratories. Their fiscal years end in different months (December 31 and March 31), so the periods don't line up exactly.

Side by side

Cytek BiosciencesMesa Laboratories
Latest fiscal yearFY2025, Dec 31, 2025FY2026, Mar 31, 2026
Revenue$202M$249M
Revenue growth0.5%3.4%
Revenue growth a year, last 5 years210.3%13.2%
Gross margin51.8%63.5%
Operating margin−20.0%7.4%
Net margin−33.0%2.7%
Free cash flow−$9M$40M
Free cash flow margin−4.3%15.9%
Return on capital—4.8%
Net debt to EBITDA—1.0x
Dividends and buybacks$15M$4M
Change in diluted share count−2.2%2.7%
Last close$5.84$139.01
P/E at the last close—120.9×
Insider trades, last 12 months——
Piotroski F-score—8 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Cytek BiosciencesMesa Laboratories
Operating margin
Percent of revenue
Cytek BiosciencesMesa Laboratories
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Cytek BiosciencesMesa Laboratories

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Cytek Biosciences and Mesa Laboratories pages.